Navigation Links
Synthetic molecule first electricity-making catalyst to use iron to split hydrogen gas
Date:2/17/2013

to test. Then, with the best-working molecule up to that point, they determined and tweaked the shape and the internal electronic forces to make additional improvements.

One of the tricks they needed the catalyst to do was to split hydrogen atoms into all of their parts. If a hydrogen atom is an egg, the positively charged proton that serves as the nucleus of the atom would be the yolk. And the electron, which orbits around the proton in a cloud, would be the white. The catalyst moves both the proton-yolks and electron-whites around in a controlled series of steps, sending the protons in one direction and the electrons to an electrode, where the electricity can be used to power things.

To do this, they need to split hydrogen molecules unevenly in an early step of the process. One hydrogen molecule is made up of two protons and two electrons, but the team needed the catalyst to tug away one proton first and send it away, where it is caught by a kind of molecule called a proton acceptor. In a real fuel cell, the acceptor would be oxygen.

Once the first proton with its electron-wooing force is gone, the electrode easily plucks off the first electron. Then another proton and electron are similarly removed, with both of the electrons being shuttled off to the electrode.

The team determined the shape and size of the catalyst and also tested different proton acceptors. With the iron in the middle, arms hanging like pendants around the edges draw out the protons. The best acceptors stole these drawn-off protons away quickly.

With their design down, the team measured how fast the catalyst split molecular hydrogen. It peaked at about two molecules per second, thousands of times faster than the closest, non-electricity making iron-based competitor. In addition, they determined its overpotential, which is a measure of how efficient the catalyst is. Coming in at 160 to 220 millivolts, the catalyst revealed itself to be similar in ef
'/>"/>

Contact: Mary Beckman
mary.beckman@pnnl.gov
509-375-3688
DOE/Pacific Northwest National Laboratory
Source:Eurekalert

Page: 1 2 3

Related biology news :

1. Synthetic Biologics to Present at the 2013 BIO CEO & Investor Conference
2. Developing microbial cell factories by employing synthetic small regulatory RNAs
3. Oscillating gel gives synthetic materials the ability to speak
4. Synthetic and biological nanoparticles combined to produce new metamaterials
5. New report finds increase in media coverage of synthetic biology
6. Synthetic fuel could eliminate US need for crude oil
7. Microchoreography: Researchers use synthetic molecule to guide cellular dance
8. Nottingham part of £20m investment for UK synthetic biology
9. Synthetic biofilter wins through to the top Sweet 16 in Boston
10. Collagen-seeking synthetic protein could lead doctors to tumor locations
11. Synthetic Biology Scorecard finds federal agencies responding to bioethics report
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/14/2015)... 14, 2015  HYPR Corp. today announced it ... ) Alliance tm , an industry consortium transforming ... to share technology and collaborate to deliver open ... more secure and private, and easier to use. ... that protects sensitive user information and eliminates the ...
(Date:4/13/2015)... 2015 According to a ... Market Forecast & Opportunities, 2020", the global biometrics market ... 14% till 2020. The biometrics market is garnering ... and review of biometric management systems. The constant ... with greater efficiency, are resulting in increasing installation ...
(Date:4/10/2015)... DUBLIN , April 10, 2015 ... the addition of the "Security Competitive Profiles - ... (Logo: http://photos.prnewswire.com/prnh/20130307/600769) , NEC will continue to ... solutions to the market, with a company focus on ... solution anticipated. Winning opportunities in the ...
Breaking Biology News(10 mins):HYPR Corp. Joins the FIDO Alliance 2HYPR Corp. Joins the FIDO Alliance 3Global Biometrics Market to Cross US$ 21 Billion by 2020: TechSci Research 2NEC Security Competitive Profile 2015 2
... Hopkins University researchers have created biodegradable nanosized particles ... and viscous mucus secretions to deliver a sustained-release ... nanoparticles, which degrade over time into harmless components, ... suffering from dozens of health conditions, including diseases ...
... the likely origin of the Devil Facial Tumour Disease (DFTD) ... team of scientists has discovered. Devil Facial Tumour ... devils and was first reported in 1996. It is spread ... characterised by large tumours, mostly on the face and mouth, ...
... chemical modification on an important muscle protein, a University of ... potentially lead to new treatments for the conditions. ... of the journal Science , may also have implications ... initially made, most proteins are modified through the addition of ...
Cached Biology News:Biodegradable particles can bypass mucus, release drugs over time 2Biodegradable particles can bypass mucus, release drugs over time 3Nervous culprit found for Tassie devil facial tumor disease 2Unusual protein modification involved in muscular dystrophy, cancer 2
(Date:5/28/2015)... Glenn Keet, CEO of Clinovo , ... Clinical Data Integration with EDC Systems ” at the ... on June 14th-18th. , During the presentation, Glenn Keet ... EDC, and will examine the value of patient engagement, ... health records/electronic medical records integration. , The presentation ...
(Date:5/28/2015)... Dr. Carl Peck, MD, Chairman ... L. Williams, MD, has joined the firm as ... are top tier consultants whose expertise and professional ... the company’s clients. Premier Experts collaborate to design ... develop their medical products, pursue optimal regulatory pathways, ...
(Date:5/27/2015)... May 27, 2015 RXi Pharmaceuticals Corporation ... on discovering and developing innovative therapies primarily in ... it has commenced a public offering of shares ... of its common stock and overallotment purchase rights ... shares of common stock, warrants and overallotment purchase ...
(Date:5/27/2015)... 2015 Expanding in a big way ... Avalon Biomed Inc. recently inked a deal with ... Co. Ltd. , the largest endodontic distributor in Japan. ... market for Avalon Biomed, which manufactures Grey MTA Plus® ... dental cements that have won renown from dentists around ...
Breaking Biology Technology:Clinovo Presents at the DIA 2015 51st Annual Meeting in Washington, DC on June 14th-18th 2Former CEO and Chair of the Council of Experts at the USP, Roger L. Williams, MD, Joins NDA Partners as a Premier Expert Consultant 2RXi Pharmaceuticals Announces Proposed Public Offering of Common Stock and Warrants 2RXi Pharmaceuticals Announces Proposed Public Offering of Common Stock and Warrants 3Dental Manufacturer Avalon Biomed Inks Major Deal with Japanese Distributor 2Dental Manufacturer Avalon Biomed Inks Major Deal with Japanese Distributor 3
... Reportlinker.com announces that a new market research report ... Global Marine Biotechnology Industry ... analyzes the Global markets for Marine Biotechnology in ... Biomaterials, Marine Bioactive Substances, and Others. The Major ...
... MYL ) today announced its financial results for the three and ... for 2011.   Financial Results ... 2010 compared to $0.33 for the same prior year quarter, an ... the year ended December 31, 2010 compared to $1.30 for the ...
... Feb. 24, 2011 Quest Diagnostics Incorporated (NYSE: ... testing, information and services, announced today that it has ... esoteric laboratory specializing in genetic testing for neurological disorders, ... for $740 million in cash.   Athena ...
Cached Biology Technology:Reportlinker Adds Global Marine Biotechnology Industry 2Mylan Reports Adjusted Diluted EPS of $0.45 for the Quarter, a 36% Increase over Prior Year Quarter; and $1.61 for the Year, a 24% Increase over Prior Year 2Mylan Reports Adjusted Diluted EPS of $0.45 for the Quarter, a 36% Increase over Prior Year Quarter; and $1.61 for the Year, a 24% Increase over Prior Year 3Mylan Reports Adjusted Diluted EPS of $0.45 for the Quarter, a 36% Increase over Prior Year Quarter; and $1.61 for the Year, a 24% Increase over Prior Year 4Mylan Reports Adjusted Diluted EPS of $0.45 for the Quarter, a 36% Increase over Prior Year Quarter; and $1.61 for the Year, a 24% Increase over Prior Year 5Mylan Reports Adjusted Diluted EPS of $0.45 for the Quarter, a 36% Increase over Prior Year Quarter; and $1.61 for the Year, a 24% Increase over Prior Year 6Mylan Reports Adjusted Diluted EPS of $0.45 for the Quarter, a 36% Increase over Prior Year Quarter; and $1.61 for the Year, a 24% Increase over Prior Year 7Mylan Reports Adjusted Diluted EPS of $0.45 for the Quarter, a 36% Increase over Prior Year Quarter; and $1.61 for the Year, a 24% Increase over Prior Year 8Mylan Reports Adjusted Diluted EPS of $0.45 for the Quarter, a 36% Increase over Prior Year Quarter; and $1.61 for the Year, a 24% Increase over Prior Year 9Mylan Reports Adjusted Diluted EPS of $0.45 for the Quarter, a 36% Increase over Prior Year Quarter; and $1.61 for the Year, a 24% Increase over Prior Year 10Mylan Reports Adjusted Diluted EPS of $0.45 for the Quarter, a 36% Increase over Prior Year Quarter; and $1.61 for the Year, a 24% Increase over Prior Year 11Mylan Reports Adjusted Diluted EPS of $0.45 for the Quarter, a 36% Increase over Prior Year Quarter; and $1.61 for the Year, a 24% Increase over Prior Year 12Mylan Reports Adjusted Diluted EPS of $0.45 for the Quarter, a 36% Increase over Prior Year Quarter; and $1.61 for the Year, a 24% Increase over Prior Year 13Mylan Reports Adjusted Diluted EPS of $0.45 for the Quarter, a 36% Increase over Prior Year Quarter; and $1.61 for the Year, a 24% Increase over Prior Year 14Mylan Reports Adjusted Diluted EPS of $0.45 for the Quarter, a 36% Increase over Prior Year Quarter; and $1.61 for the Year, a 24% Increase over Prior Year 15Mylan Reports Adjusted Diluted EPS of $0.45 for the Quarter, a 36% Increase over Prior Year Quarter; and $1.61 for the Year, a 24% Increase over Prior Year 16Mylan Reports Adjusted Diluted EPS of $0.45 for the Quarter, a 36% Increase over Prior Year Quarter; and $1.61 for the Year, a 24% Increase over Prior Year 17Mylan Reports Adjusted Diluted EPS of $0.45 for the Quarter, a 36% Increase over Prior Year Quarter; and $1.61 for the Year, a 24% Increase over Prior Year 18Quest Diagnostics to Acquire Athena Diagnostics, Establishing Leading Position in Rapidly Growing Neurology Testing Market 2Quest Diagnostics to Acquire Athena Diagnostics, Establishing Leading Position in Rapidly Growing Neurology Testing Market 3Quest Diagnostics to Acquire Athena Diagnostics, Establishing Leading Position in Rapidly Growing Neurology Testing Market 4
Rabbit polyclonal to MCP2 ( Abpromise for all tested applications). entrezGeneID: 6355 SwissProtID: P49873...
... A sensitive and high speed homogeneous assay ... activity and for screening of inhibitors in ... is based on a fluorescence superquenching technology ... label. The universal platform provides flexibility for ...
... with PowerPac 3000 power supply, 220-240 V, ... by liquid-phase isoelectric focusing (IEF). The system ... standard (60 ml) focusing chambers, chassis, harvesting ... power supply, 10 ml Bio-Lyte ampholytes (pH ...
... purification system, 100-120 V, is used for ... focusing (IEF). The system includes both the ... focusing chambers, chassis, harvesting apparatus, cooling finger, ... 3-10), 60 ml syringe, colored protein sample, ...
Biology Products: